{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:37:01Z","timestamp":1787009821184,"version":"build-2736575974"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1097\/aco.0000000000000617","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T14:39:25Z","timestamp":1527172765000},"page":"439-445","source":"Crossref","is-referenced-by-count":29,"title":["Emerging evidence for antidepressant actions of anesthetic agents"],"prefix":"10.1097","volume":"31","author":[{"given":"Scott C.","family":"Tadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Mickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R6-9-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12893-016-0120-y","article-title":"Depression and postoperative complications: an overview","volume":"16","author":"Ghoneim","year":"2016","journal-title":"BMC Surg"},{"key":"R7-9-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"R14-9-20210129","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R15-9-20210129","first-page":"5","article-title":"The burden of recurrent depression: causes, consequences, and future prospects","volume":"62","author":"Greden","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"R16-9-20210129","first-page":"17","article-title":"Prevalence and management of treatment-resistant depression","volume":"68","author":"Nemeroff","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R17-9-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1176\/appi.ps.201300059","article-title":"A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013","volume":"65","author":"Mrazek","year":"2014","journal-title":"Psychiatr Serv"},{"key":"R18-9-20210129","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: a multiscale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"R19-9-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamapsychiatry.2016.2586","article-title":"Toward an evidence-based, operational definition of treatment-resistant depression: when enough is enough","volume":"74","author":"Conway","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R20-9-20210129","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/mp.2015.92","article-title":"Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder","volume":"20","author":"Papakostas","year":"2015","journal-title":"Mol Psychiatry"},{"key":"R21-9-20210129","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1056\/NEJMct075234","article-title":"Electroconvulsive therapy for depression","volume":"357","author":"Lisanby","year":"2007","journal-title":"N Engl J Med"},{"key":"R23-9-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/dta.1620","article-title":"From PCP to MXE: a comprehensive review of the nonmedical use of dissociative drugs","volume":"6","author":"Morris","year":"2014","journal-title":"Drug Test Anal"},{"key":"R24-9-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologoical effects of CI-581, a new dissociative anesthetic, in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clin Pharmacol Therap"},{"key":"R25-9-20210129","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s12630-011-9560-0","article-title":"A systematic review of intravenous ketamine for postoperative analgesia","volume":"58","author":"Laskowski","year":"2011","journal-title":"Can J Anaesth"},{"key":"R26-9-20210129","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1097\/j.pain.0000000000000705","article-title":"Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain: systematic review and meta-analyses of randomized controlled trials with trial sequential analyses","volume":"157","author":"Assouline","year":"2016","journal-title":"Pain"},{"key":"R27-9-20210129","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ejp.1153","article-title":"Ketamine for chronic noncancer pain: a meta-analysis and trial sequential analysis of randomized controlled trials","volume":"22","author":"Michelet","year":"2018","journal-title":"Eur J Pain"},{"key":"R28-9-20210129","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"R29-9-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine response","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"R30-9-20210129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R31-9-20210129","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R32-9-20210129","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and nonketamine N-methyl-D- aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol Med"},{"key":"R33-9-20210129","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"R34-9-20210129","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.4088\/JCP.17f11738","article-title":"Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency?","volume":"78","author":"Andrade","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"R35-9-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","article-title":"Continuation phase intravenous ketamine in adults with treatment-resistant depression","volume":"206","author":"Vande Voort","year":"2016","journal-title":"J Affect Disord"},{"key":"R36-9-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00000539-200207000-00020","article-title":"Small-dose ketamine improves the postoperative state of depressed patients","volume":"95","author":"Kudoh","year":"2002","journal-title":"Anesth Analg"},{"key":"R37-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2016.05.076","article-title":"Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trial","volume":"204","author":"Jafarinia","year":"2016","journal-title":"J Affect Disord"},{"key":"R38-9-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1192\/bjp.bp.116.195826","article-title":"Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis","volume":"210","author":"McGirr","year":"2017","journal-title":"Br J Psychiatry"},{"key":"R39-9-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jad.2017.11.034","article-title":"A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression","volume":"227","author":"Zhang","year":"2018","journal-title":"J Affect Disord"},{"key":"R40-9-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S2215-0366(17)30077-9","article-title":"Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial","volume":"4","author":"Anderson","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"R41-9-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"R42-9-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12264-016-0081-2","article-title":"Risks associated with misuse of ketamine as a rapid-acting antidepressant","volume":"32","author":"Zhu","year":"2016","journal-title":"Neurosci Bull"},{"key":"R43-9-20210129","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00000542-198111000-00014","article-title":"Isoflurane: a review","volume":"55","author":"Eger","year":"1981","journal-title":"Anesthesiology"},{"key":"R44-9-20210129","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00000542-197111000-00010","article-title":"The electroencephalogram in man anesthetized with forane","volume":"35","author":"Eger","year":"1971","journal-title":"Anesthesiology"},{"key":"R45-9-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000118216","article-title":"Rapid psychotherapeutic effects of anesthesia with isoflurane (ES narcotherapy) in treatment-refractory depressed patients","volume":"14","author":"Langer","year":"1986","journal-title":"Neuropsychobiology"},{"key":"R46-9-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/YCT.0b013e3182622c0e","article-title":"Burst suppression: a more valid marker of postictal central inhibition?","volume":"29","author":"Kranaster","year":"2013","journal-title":"J ECT"},{"key":"R47-9-20210129","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1055\/s-2007-1017040","article-title":"Open comparative study with treatment-refractory depressed patients: electroconvulsive therapy--anesthetic therapy with isoflurane (preliminary report)","volume":"21","author":"Carl","year":"1988","journal-title":"Pharmacopsychiatry"},{"key":"R48-9-20210129","first-page":"113","article-title":"Intra-individual open comparison of burst- suppression-isoflurane-anaesthesia versus electroconvulsive therapy in the treatment of severe depression","volume":"10","author":"Engelhardt","year":"1993","journal-title":"Eur J Anesthesiol"},{"key":"R49-9-20210129","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000119190","article-title":"Isoflurane narcotherapy in depressive patients refractory to conventional antidepressant drug treatment","volume":"31","author":"Langer","year":"1995","journal-title":"Neuropsychobiology"},{"key":"R50-9-20210129","first-page":"269","article-title":"Isoflurane anesthesia therapy: a replacement for ECT in depressive disorders?","volume":"3","author":"Greenberg","year":"1987","journal-title":"Convuls Ther"},{"key":"R51-9-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00124509-200112000-00009","article-title":"Inefficacy of burst-suppression anesthesia in medication-resistant major depression: a controlled trial","volume":"17","author":"Garc\u00eda-Toro","year":"2001","journal-title":"J ECT"},{"key":"R52-9-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1258\/la.2007.06019e","article-title":"Comparative effects of halothane, isoflurane, sevoflurane and desflurane on the electroencephalogram of the rat","volume":"42","author":"Murrell","year":"2008","journal-title":"Lab Anim"},{"key":"R53-9-20210129","first-page":"212","article-title":"Isoflurane demonstrates antidepressant-like activity in a mouse model of depression (Abstract)","volume":"108","author":"Tadler","year":"2009","journal-title":"Anesth Analg"},{"key":"R54-9-20210129","first-page":"e3638","article-title":"The mouse forced swim test","volume":"59","author":"Can","year":"2012","journal-title":"J Vis Exp"},{"key":"R55-9-20210129","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1038\/s41598-017-08166-9","article-title":"Isoflurane produces antidepressant effects and induces TrkB signaling in rodents","volume":"7","author":"Antila","year":"2017","journal-title":"Sci Rep"},{"key":"R56-9-20210129","first-page":"1","article-title":"Isoflurane but not halothane prevents and reverses helpless behavior: a role for EEG burst suppression?","volume":"00","author":"Brown","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"R57-9-20210129","doi-asserted-by":"crossref","first-page":"e69809","DOI":"10.1371\/journal.pone.0069809","article-title":"Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression","volume":"8","author":"Weeks","year":"2013","journal-title":"PLoS One"},{"key":"R58-9-20210129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biopsych.2014.11.016","article-title":"Nitrous oxide for treatment-resistant major depression: a proof-of-concept trial","volume":"78","author":"Nagele","year":"2015","journal-title":"Biol Psychiatry"},{"key":"R59-9-20210129","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.jvca.2015.01.022","article-title":"Total intravenous anesthesia and anesthetic outcomes","volume":"29","author":"Miller","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R60-9-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bja\/aeu016","article-title":"Burst suppression-MAC and burst suppression-CP50 as measures of cerebral effects of anaesthetics","volume":"112","author":"Pilge","year":"2014","journal-title":"Br J Anaesth"},{"key":"R61-9-20210129","first-page":"ONS369","article-title":"Total intravenous anesthesia: advantages for intracranial surgery","volume":"61","author":"Cole","year":"2007","journal-title":"Neurosurgery"},{"key":"R62-9-20210129","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1139\/cjpp-2017-0243","article-title":"Propofol attenuates BV2 microglia inflammation via NMDA receptor inhibition","volume":"96","author":"Wu","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"R63-9-20210129","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1476-5381.1995.tb16660.x","article-title":"Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones","volume":"116","author":"Orser","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R64-9-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuroscience.2017.10.019","article-title":"Propofol protects rat hypoglossal motoneurons in an in vitro model of excitotoxicity by boosting GABAergic inhibition and reducing oxidative stress","volume":"367","author":"Ghezzi","year":"2017","journal-title":"Neuroscience"},{"key":"R65-9-20210129","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000542-200604000-00021","article-title":"Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons","volume":"104","author":"Kingston","year":"2006","journal-title":"Anesthesiology"},{"key":"R66-9-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806917737462","article-title":"Propofol produces preventive analgesia via GluN2B-containing NMDA receptor\/ERK1\/2 signaling pathway in a rat model of inflammatory pain","volume":"13","author":"Qiu","year":"2017","journal-title":"Mol Pain"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000000617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T18:49:39Z","timestamp":1620931779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201808000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000000617","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}